Categories
2023 Press Releases

Farmacosmo: Group Revenues Of €18.8 Million (+6% YoY) Driven By Online Retail Channel (+22% YoY)

Farmacosmo: Group Revenues Of €18.8 Million (+6% YoY) Driven By Online Retail Channel (+22% YoY)

Categories
2023 Press Releases

Notice of Ordinary Shareholders’ Meeting

Notice of Ordinary Shareholders’ Meeting

Categories
2023 Press Releases

Change to the 2023 Corporate Events Calendar

Change to the 2023 Corporate Events Calendar

Categories
2023 Press Releases

Farmacosmo Starts Branding Its First Physical Pharmacies

Farmacosmo Starts Branding Its First Physical Pharmacies

Categories
2023 Press Releases

FARMACOSMO: Board of Directors Approves Draft Financial Statements and Consolidated Financial Statements to 31 December 2022

FARMACOSMO: Board of Directors Approves Draft Financial Statements and Consolidated Financial Statements to 31 December 2022

Categories
2023 Press Releases

Change To The 2023 Corporate Events Calendar

Change To The 2023 Corporate Events Calendar

Categories
2023 Press Releases

Closing For The Acquisition Of The Share Capital Of Telepsicologia S.R.L. The Launch Of Contactu Platform Is Scheduled For March 24

Closing For The Acquisition Of The Share Capital Of Telepsicologia S.R.L. The Launch Of Contactu Platform Is Scheduled For March 24

Categories
2023 Press Releases

Farmacosmo Launches Contactu, A Digital Psychology And Psychotherapy Online Platform

Farmacosmo Launches Contactu, A Digital Psychology And Psychotherapy Online Platform

Categories
2023 Press Releases

Farmacosmo: 2022 Pro-Forma Revenue At 76 Mln (+31% Yoy) The Growth Of Farmacosmo Continues Revenues Of 63,4 Million Up By C. 10% Yoy

Farmacosmo: 2022 Pro-Forma Revenue At 76 Mln (+31% Yoy) The Growth Of Farmacosmo Continues Revenues Of 63,4 Million Up By C. 10% Yoy

Categories
2023 Press Releases

Closing For The Acquisition Of Bau Cosmesi Portal After The Operation Farmacosmo Will Detain 67% Of The Company Owner Of The Portal

Closing For The Acquisition Of Bau Cosmesi Portal After The Operation Farmacosmo Will Detain 67% Of The Company Owner Of The Portal